Bob Yedid | IR, LifeSci Advisors |
William Annett | President and CEO |
Mitch Levine | CFO |
Lyndal Hesterberg | SVP, Research & Development |
Bill Quirk | Piper Jaffray |
Bruce Jackson | The Benchmark Company |
Casey Woodring | Janney Montgomery Scott |
Good day and welcome to the OncoCyte Conference Call to discuss First Quarter 2019 Financial Results and Operating Highlights. Today's call is being recorded. At this time, I would like to turn the call over to Bob Yedid of LifeSci Advisors. Please go ahead.
Thank you, operator and thanks everyone for joining us for this afternoon's conference call to discuss OncoCyte's first quarter 2019 financial results and recent operating highlights.